LONN; Hans Roland

Patent Applications and Registrations

Patent applications and USPTO patent grants for LONN; Hans Roland.The latest application filed is for "certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasis".

Company Profile

6.6.12

LONN; Hans Roland - Cheshire GB
LONN; Hans Roland - Lund SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides For Treating Bronchiectasis App 20220133737 - LONN; Hans Roland ; et al.	2022-05-05
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors Grant 11,117,874 - Lonn , et al. September 14, 2	2021-09-14
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors App 20210238152 - LONN; Hans Roland ; et al.	2021-08-05
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors App 20200247765 - Kind Code	2020-08-06
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides For Treating Bronchiectasis App 20200179398 - LONN; Hans Roland ; et al.	2020-06-11
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors Grant 10,669,245 - Lonn , et al.	2020-06-02
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors App 20200017455 - LONN; Hans Roland ; et al.	2020-01-16
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors Grant 10,287,258 - Lonn , et al.	2019-05-14
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides For Treating Bronchiectasis App 20190091236 - Lonn; Hans Roland ; et al.	2019-03-28
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors App 20180251436 - LONN; Hans Roland ; et al.	2018-09-06
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors For Treating Bronchiectasis App 20180028541 - LONN; Hans Roland ; et al.	2018-02-01
Certain (25)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors Grant 9,815,805 - Lonn , et al. November 14, 2	2017-11-14
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors App 20170057938 - LONN; Hans Roland ; et al.	2017-03-02
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors Grant 9,522,894 - Lonn , et al. December 20, 2	2016-12-20
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides As Dipeptidyl Peptidase 1 Inhibitors App 20150210655 - LONN; Hans Roland ; et al.	2015-07-30
Novel Salt 628 App 20120269872 - BRIGGNER; Lars-Erik ; et al.	2012-10-25
Salt 628 Grant 8,232,296 - Briggner , et al. July 31, 2	2012-07-31
Novel Salt 628 App 20100216843 - Briggner; Lars-Erik ; et al.	2010-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.